
BioMed Realty Trust , Inc. ( BMR ) Q1 2013 Earnings Call May ..... Welcome to the First Quarter 2013 BioMed Realty Trust , Inc. Earnings Conference Call ..... com/article/1396491- biomed - realty - trust -s-ceo-discusses-q1
Notable earnings after Wednesday’ s close: ALL , ARI , ARR , ATML , ATO , ATW , AXLL , AXTI , BKD , BMR , CACI , CAR , CBS , CJES , CNQR , CSOD , CVD , CVI , CVRR , CWT , CXO , DVR , DX , DXCM , DXPE , EDMC , ESS , EXPD , EXXI , FB
We are lowering our moat rating for BioMed Realty Trust BMR to none from narrow, because of higher estimated property maintenance expenditures. Incorporating higher property maintenance
The uncertainty surrounding long-term tenant viability is high for life sciences landlords relative to other property types. Many of BioMed's life sciences tenants lack proven, long-term revenue streams and are instead reliant upon investment capital for early-stage development expenses. Relative
We are placing BioMed Realty Trust BMR under review as we transfer coverage to a new analyst.
We are maintaining our $21 fair value estimate and narrow moat rating for BioMed Realty Trust BMR following its $640 million acquisition of privately held life sciences real estate peer Wexford Science & Technology. Although
Biomed Realty Trust Inc ( BMR ) declares $0.235/share quarterly dividend, in line with previous. Forward yield 4.30%. For shareholders of record Mar. 28. Payable Apr. 15. Ex-div date Mar. 26. ( PR ) Post your comment!
that has been in my inc ome portfolio for some time, BioMed Realty Trust ( BMR ). My last synopsis of how the company was doing ..... have slow but steady upside in them. Recent news on BMR : Keybanc upgraded the stock from "Hold
BioMed Realty Trust , Inc. ( BMR ) Q4 2012 Earnings Call February 6, 2013 ..... the fourth quarter, 2012, BioMed Realty Trust earnings conference call. My ..... com/article/1162011- biomed - realty - trust -s-ceo-discusses-q4
Landlord to the life sciences industry BioMed Realty Trust BMR reported solid fourth-quarter results that were near our expectations, and we will not change our $21 fair value estimate